* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Plasma Protein Binding
Discovery and development of non-nucleoside reverse-transcriptase inhibitors wikipedia , lookup
Prescription costs wikipedia , lookup
Neuropsychopharmacology wikipedia , lookup
Discovery and development of direct thrombin inhibitors wikipedia , lookup
Nicotinic agonist wikipedia , lookup
Discovery and development of integrase inhibitors wikipedia , lookup
Pharmacogenomics wikipedia , lookup
Discovery and development of tubulin inhibitors wikipedia , lookup
Discovery and development of proton pump inhibitors wikipedia , lookup
Discovery and development of angiotensin receptor blockers wikipedia , lookup
Discovery and development of cephalosporins wikipedia , lookup
Discovery and development of cyclooxygenase 2 inhibitors wikipedia , lookup
Discovery and development of direct Xa inhibitors wikipedia , lookup
Discovery and development of antiandrogens wikipedia , lookup
Drug discovery wikipedia , lookup
Drug interaction wikipedia , lookup
Neuropharmacology wikipedia , lookup
Plateau principle wikipedia , lookup
Plasma Protein Binding 2014.1.24 Jun Min Jung Overview Compounds can bind to albumin, α1-acid glycoprotein, or lipoproteins in blood. Binding reduces free drug in solution for penetration into tissue to reach the therapeutic target or to the liver and kidney for elimination. Components of Plasma Blood plasma Consists of: Water 90% Plasma Proteins 6-8 % Electrolytes (Na+ & Cl-) 1% Other components: Nutrients (e.g. Glucose and amino acids) Hormones (e.g. Cortisol, thyroxine) Wastes (e.g. Urea) Blood gases (e.g. CO2, O2) Plasma Protein Binding Fundamentals The interaction of drug molecules with plasma proteins is electrostatic. Binding usually is rapid, average equilibrium time of 20ms. Most delivery routes are oral dosing, intravenous injection, intraperitoneal, intramuscular, subcutaneous, transdermal, transfer drug Intravenous (정맥), intraperitoneal (복강), intramuscular (근육), subcutaneous (피하), transdermal (피부) Percent of unbound, compared to rat and dog in human, is 10- and 20- fold lower resulting lower clearance. Two plasma proteins that are most responsible for binding of drug Albumin which in human is called HSA (human serum albumin) Primary functions are maintaining blood pH, osmotic pressure, and transport molecules AGP (acid glycoprotein) Primary function is to carry steroids Albumin Albumin (66.5 kDa), single polypeptide chain having 585 aa with 17 disul fide bonds, is the most abundant protein (60%) in the blood plasma. (3.5-5. 0 g/dl) Transport: It can bind and transport many diverse molecules and serve as lo w-specificity transport protein, which include: ◦ a. Metal ions ◦ b. Free fatty acid ◦ c. Bilirubin ◦ d. Bile acid ◦ e. Hormones Site I Site II AGP (acid glycoprotein) Consists 181 aa in a single polypeptide chain and MW of 44kDa Very high carbohydrate content (45%) and very acidic isoelectric point around 3 I. I. I. Class I drugs – Warfarin (경구용 항응고제), Diazepam (진정제) One to three binding sites per molecule, saturable Class II drugs – Indomethacin (소염제) Binds moderately to HSA, six bindings per HSA molecule Class III drugs – Phenytoin(항간질제) Weak HSA binding, many binding sites per molecule I. Class IV-Digitoxin(심장강화제) Binds to HSA, not saturable Class V-Erythromycin(항생물질) I. Binds to HSA, can be saturated I. Class VI-Imipramine(신경진정제) Binds to HSA, AGP, lipoproteins(HDL, LDL, VLDL) Consequence of Chirality on PPB PPB affects compound distribution, metabolism, and renal clearance Propranolol (부정맥 치료제) Warfarin (경구용 항응고제) Disopyramide (항부정맥 치료제) Verapamil (칼슘길항제) Indacrinone (이뇨제) PPB Effects Free Drug Hypothesis I. Drug-plasma protein complex cannot permeate through cell membranes by passive transcellular permeation II. Free drug passes through membranes to reach tissues III. Free drug molecules are available for liver metabolism and renal excretion Two complementary factors of PBB I. Extent of binding at equilibrium (percent bound or percent unbound in plasma[fu,plasma], equilibrium dissociation constant Kd) II. Rate of association and dissociation (association and dissociation rate constant Kd and Ka) If the drug molecules are 1. Highly bound (low % unbound) 2. Tightly bound (slow dissociation) then effects of PPB can be as follows I. Retain drug in plasma II. Restrict distribution of drug into target tissue III. Decrease metabolism, clearance, prolong (half life) IV. Limit brain penetration V. Require higher loading doses but lower maintenance doses High % bound, slow dissociation Restrictive Fast kinetics(high dissociation rate) Permissive In short, high binding to plasma protein (high % bound) alone does not itself determine the consequences of plasma binding Impact of PPB on Distribution PPB can have either ‘Restrictive’ or ‘Permissive’ PPB also can be restrictive of BBB permeation Binding keeps in bloodstream resulting reduced permeation Vd – Volume of distribution Vplasma – Volume of plasma in the body Vtissue – volume of tissue in the body Fu - fraction unbound in the plasma Fu,t – fraction unbound in the tissue Effect of PPB on Clearance & Pharmacology Propranolol - >90% PPB, permissive of 90% liver extraction Warfarin – 99% PPB, restrictive of 0.3% liver extraction PPB reduces vascular receptor occupancy No diffusion barriers For example, angiotensin II decreased by adding albumin Structure Modification Strategies for PPB Plasma Protein Binding Methods Literature and commercial in silico predictors of plasma protein binding are available Equilibrium dialysis is the gold standard method. Ultrafiltration, ultracentrifugation, microdialysis, and plasmom resonance methods are used Red blood cell binding is important to measure for some compounds Equilibrium Dialysis Method Ultrafiltration Method Problems